EligibleTrials

Swiss Dermatology Network of Targeted Therapies (SDNTT)

Recruiting · NCT01706692 · Observational (researchers observe without assigning treatment) · Lead sponsor: Swiss Dermatology Network for Targeted Therapies

View the official record on ClinicalTrials.gov →
Psoriasis

Interventions studied

AdalimumabCyclosporine AEtanerceptFumaric acidsInfliximabMethotrexateOther anti-psoriatic systemic treatmentsUstekinumab

What this trial is about

The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will remain in the registry for 10 years, regardless of subsequent therapy. The registry will also evaluate safety clinical outcomes and health related quality of life.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

6 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.